ipilimumab,nivolumab
bms
['checkmate 743', 'nivo', 'check,mate,743', ' ipi ']
checkmate 743 update in 1l unresectable mpm: nivo + ipi continued to provide long-term, durable benefit versus chemo 4-yr os : 17% vs 11% 4-yr pfs : 9% vs 0% 16% of responders in the nivo + ipi arm have ongoing response at 4 yr (vs 0). #esmo22 
MD, PhD, Prof of Respiratory Medicine, Thoracic Oncology Specialist @CHUdeToulouse, @IUCTOncopoleICR; Researcher, INSERM @crctoncopole #LCSM ????? ?? ??